Advancements in nanotherapeutics targeting senescence in chronic obstructive pulmonary disease

Keshav Raj Paudel; Meenu Mehta; Shakti Dhar Shukla; Nisha Panth; Dinesh Kumar Chellappan; Kamal Dua; Philip Hansbro

doi:10.2217/nnm-2021-0373

Advancements in nanotherapeutics targeting senescence in chronic obstructive pulmonary disease

Keshav Raj Paudel
, Meenu Mehta
, Shakti Dhar Shukla
, Nisha Panth
, Dinesh Kumar Chellappan
, Kamal Dua
, Philip Hansbro

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic airway disease. It is characterized by severe inflammation mediated by inflammatory cells such as macrophages, neutrophil influx, emphysema due to loss of alveolar-capillary units and poorly reversible impairment in lung function. The primary risk factor for COPD is cigarette smoking.

Original language	English
Pages (from-to)	1757-1760
Number of pages	4
Journal	Nanomedicine
Volume	17
Issue number	23
DOIs	https://doi.org/10.2217/nnm-2021-0373
Publication status	Published - Oct 2022
Externally published	Yes

Keywords

chronic obstructive pulmonary disease
drug delivery
nanotherapeutics
pulmonary
senescence

Access to Document

10.2217/nnm-2021-0373

Cite this

@article{3256208d7c364a799345acd610cced8b,

title = "Advancements in nanotherapeutics targeting senescence in chronic obstructive pulmonary disease",

abstract = "Chronic obstructive pulmonary disease (COPD) is a chronic airway disease. It is characterized by severe inflammation mediated by inflammatory cells such as macrophages, neutrophil influx, emphysema due to loss of alveolar-capillary units and poorly reversible impairment in lung function. The primary risk factor for COPD is cigarette smoking.",

keywords = "chronic obstructive pulmonary disease, drug delivery, nanotherapeutics, pulmonary, senescence",

author = "Paudel, \{Keshav Raj\} and Meenu Mehta and Shukla, \{Shakti Dhar\} and Nisha Panth and Chellappan, \{Dinesh Kumar\} and Kamal Dua and Philip Hansbro",

year = "2022",

month = oct,

doi = "10.2217/nnm-2021-0373",

language = "English",

volume = "17",

pages = "1757--1760",

journal = "Nanomedicine",

issn = "1743-5889",

publisher = "Taylor \& Francis",

number = "23",

}

TY - JOUR

T1 - Advancements in nanotherapeutics targeting senescence in chronic obstructive pulmonary disease

AU - Paudel, Keshav Raj

AU - Mehta, Meenu

AU - Shukla, Shakti Dhar

AU - Panth, Nisha

AU - Chellappan, Dinesh Kumar

AU - Dua, Kamal

AU - Hansbro, Philip

PY - 2022/10

Y1 - 2022/10

N2 - Chronic obstructive pulmonary disease (COPD) is a chronic airway disease. It is characterized by severe inflammation mediated by inflammatory cells such as macrophages, neutrophil influx, emphysema due to loss of alveolar-capillary units and poorly reversible impairment in lung function. The primary risk factor for COPD is cigarette smoking.

AB - Chronic obstructive pulmonary disease (COPD) is a chronic airway disease. It is characterized by severe inflammation mediated by inflammatory cells such as macrophages, neutrophil influx, emphysema due to loss of alveolar-capillary units and poorly reversible impairment in lung function. The primary risk factor for COPD is cigarette smoking.

KW - chronic obstructive pulmonary disease

KW - drug delivery

KW - nanotherapeutics

KW - pulmonary

KW - senescence

UR - https://www.scopus.com/pages/publications/85148307443

UR - https://go.openathens.net/redirector/westernsydney.edu.au?url=https://doi.org/10.2217/nnm-2021-0373

U2 - 10.2217/nnm-2021-0373

DO - 10.2217/nnm-2021-0373

M3 - Article

C2 - 35060764

AN - SCOPUS:85148307443

SN - 1743-5889

VL - 17

SP - 1757

EP - 1760

JO - Nanomedicine

JF - Nanomedicine

IS - 23

ER -

Advancements in nanotherapeutics targeting senescence in chronic obstructive pulmonary disease

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this